| HLA genetic polymorphisms and prognosis of patients with COVID-19 L Lorente, MM Martín, A Franco, Y Barrios, JJ Cáceres, J Solé-Violán, ... Medicina intensiva 45 (2), 96-103, 2021 | 122 | 2021 |
| Length of the antibody heavy chain complementarity determining region 3 as a specificity‐determining factor Y Barrios, P Jirholt, M Ohlin Journal of Molecular Recognition 17 (4), 332-338, 2004 | 97 | 2004 |
| Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma Y Barrios, R Cabrera, R Yáñez, M Briz, A Plaza, R Forés, MN Fernández, ... Haematologica 87 (4), 400-407, 2002 | 76 | 2002 |
| Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma R Cabrera, F Diaz-Espada, Y Barrios, M Briz, R Fores, L Barbolla, ... Bone marrow transplantation 25 (10), 1105-1108, 2000 | 47 | 2000 |
| Omalizumab for drug allergy V Matheu, A Franco, E Perez, M Hernández, Y Barrios Journal of Allergy and Clinical Immunology 120 (6), 1471-1472, 2007 | 32 | 2007 |
| Impact on allergic immune response after treatment with vitamin A V Matheu, K Berggård, Y Barrios, Y Barrios, MR Arnau, JM Zubeldia, ... Nutrition & metabolism 6, 1-11, 2009 | 25 | 2009 |
| Human monoclonal antibodies produced in transgenic BABκ, λ mice recognising idiotypic immunoglobulins of human lymphoma cells E Suárez, R Yáñez, Y Barrios, F Dı́az-Espada Molecular immunology 41 (5), 519-526, 2004 | 25 | 2004 |
| Downregulation of angiogenesis factors, VEGF and PDGF, after rapid IgE desensitization and oral immunotherapy in children with food allergy P Poza-Guedes, Y Barrios, V Fuentes, A Franco, I Sánchez-Machín, ... BioMed research international 2014 (1), 372567, 2014 | 20 | 2014 |
| T cell activity in successful treatment of chronic urticaria with omalizumab I Sánchez-Machín, J Iglesias-Souto, A Franco, Y Barrios, R Gonzalez, ... Clinical and Molecular Allergy 9, 1-3, 2011 | 20 | 2011 |
| Chain shuffling to modify properties of recombinant immunoglobulins J Lantto, P Jirholt, Y Barrios, M Ohlin Antibody Phage Display: Methods and Protocols, 303-316, 2002 | 18 | 2002 |
| Anti-idiotypic immunotherapy in follicular lymphoma patients: results of a long follow-up study R Yáñez, Y Barrios, E Ruiz, R Cabrera, F Díaz-Espada Journal of Immunotherapy 31 (3), 310-312, 2008 | 17 | 2008 |
| A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals Y Barrios, A Franco, I Sanchez-Machin, P Poza-Guedes, ... Clinical Immunology 226, 108730, 2021 | 14 | 2021 |
| Evaluation of major mite allergens from European standardized commercial extracts for in vivo diagnosis: addressing the need for precision medicine R González-Pérez, P Poza-Guedes, Y Barrios del Pino, V Matheu, ... Clinical and Translational Allergy 9 (1), 1-8, 2019 | 13 | 2019 |
| The beauty of simplicity: delayed-type hypersensitivity reaction to measure cellular immune responses in RNA-SARS-Cov-2 vaccinated individuals Y Barrios, A Franco, I Sánchez-Machín, P Poza-Guedes, ... Vaccines 9 (6), 575, 2021 | 12 | 2021 |
| Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties Y Barrios, S Knör, J Lantto, M Mach, M Ohlin Molecular Immunology 44 (5), 680-690, 2007 | 12 | 2007 |
| Severe cutaneous vasculitis following intravenous infusion of gammaglobulin in a patient with type II mixed cryoglobulinemia M Yebra, Y Barrios, J Rincon, I Sanjuan, F Diaz-Espada Clinical and experimental rheumatology 20 (2), 225-227, 2002 | 12 | 2002 |
| Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients Y Barrios, A Franco, C Alava-Cruz, R Cuesta-Martin, C Camara, V Matheu Allergologia et Immunopathologia 50 (3), 101-105, 2022 | 9 | 2022 |
| Role of specific IgE to β-lactoglobulin in the gastrointestinal phenotype of cow’s milk allergy P Poza-Guedes, Y Barrios, R González-Pérez, I Sánchez-Machín, ... Allergy, Asthma & Clinical Immunology 12, 1-4, 2016 | 9 | 2016 |
| Isolated Ro52 antibodies as immunological marker of a mild phenotype of undifferentiated connective tissue diseases A Alonso-Larruga, S Bustabad, JA Navarro-Gonzálvez, ... International Journal of Rheumatology 2017 (1), 3076017, 2017 | 8 | 2017 |
| Tratamiento de inducción combinando inmunoglobulinas, plasmaféresis y rituximab en pacientes hipersensibilizados que reciben trasplante renal de cadáver JM Rufino Hernández, E Cabello Moya, JM González-Posada, ... Nefrología (Madrid) 30 (2), 252-257, 2010 | 7 | 2010 |
